DRUG · Unmapped registry intervention
Paclitaxel, Carboplatin
Find medicine records ·
Find other trials using this name
Clinical trial
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
NCT01203267
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedWeekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Sponsors & collaborators
Shanghai Jiao Tong University School of Medicinelead sponsor
Fudan Universitycollaborator
Ruijin Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01203267 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.